PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFlorbetapir f-18
Florbetapir f-18
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
105 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Alzheimer diseaseD000544EFO_0000249F032516742573
Cognitive dysfunctionD060825G31.8431132927
AmyloidosisD000686EFO_1001875E851313714
Multiple sclerosisD009103EFO_0003885G351113
SclerosisD0125981113
Postoperative cognitive complicationsD00007969011
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DementiaD003704EFO_0003862F03361715
Nerve degenerationD0094101113
Cognition disordersD003072123
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinson diseaseD010300EFO_0002508G203327
Healthy volunteers/patients516
Traumatic brain injuriesD000070642S061326
Amyloid plaqueD058225314
Frontotemporal dementiaD057180G31.01214
Primary progressive aphasiaD018888EFO_0009053G31.011214
Pick disease of the brainD020774EFO_0003096G31.011214
Brain diseasesD001927G93.401214
Chronic traumatic encephalopathyD0000706271214
Brain injuriesD001930S06.9123
Show 13 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Progressive supranuclear palsyD013494EFO_0002512G23.144
Neuroinflammatory diseasesD00009086211
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Immunoglobulin light-chain amyloidosisD00007536322
HemorrhageD006470MP_0001914R5822
Affective symptomsD00034211
AphasiaD001037R47.0111
Down syndromeD004314EFO_0001064Q9011
SyndromeD01357711
CardiomyopathiesD009202EFO_0000318I4211
HydrocephalusD006849G9111
Normal pressure hydrocephalusD006850EFO_1001065G91.211
Cerebral hemorrhageD00254311
Show 11 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,801 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
93 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use